Alivus Life Sciences Limited (ALIVUS)
Market Closed
10 Aug, 10:00
XNSE XNSE Primary ₹
1,374. 50
+44.7
+3.3614%
₹
130.3B Market Cap
- P/E Ratio
5% Div Yield
342,633 Volume
- Eps
₹ 1,329.8
Previous Close Want to track ALIVUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alivus Life Sciences Limited (ALIVUS) Statistics
Valuation metrics
Market Cap 130.3B
Enterprise value 163.76B
Trailing P/E (ttm) 27.07
Forward P/E 18.26
PEG ratio 1.26
Price/Sales (ttm) 6.3
Price/Book (mrq) 4.9
Enterprise Value/Revenue 6.32
Enterprise Value/EBITDA 18.73
Overview
Shares outstanding 122.74M
Float 30.89M
Shares short -
% Held by insiders 0.76%
% Held by institutions 0.08%
Average volume (10 days) 271.65K
Average volume (90 days) 119.03K
Price summary
52-Week low 819
52-Week high 1,387.4
Beta -
50-Day moving average 1,157.37
200-Day moving average 1,034.36
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.23%
Operating margin 0.29%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.2%
Income Statement
Revenue (ttm) 26.12B
Revenue per share (ttm) 211.05
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 15.46B
EBITDA 8.36B
Net income to common (ttm) 5.64B
Diluted EPS (ttm) 49.13
Quarterly earnings growth (yoy) 0.15%
Balance Sheet
Total cash (mrq) 7.83B
Total cash per share (mrq) 63.75
Total debt (mrq) 567.71M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 5.21%
Book value per share (mrq) 271.48
Cash Flow
Cash flow statement 5.65B
Levered free cash flow (LFCF) 2.09B
